Evaluation of the Association Between Epstein-Barr Virus and Mycosis Fungoides

Yalda Nahidi1, Naser Tayyebi Meibodi2, Kiarash Ghazvini3

  • 1Department of Dermatology, Cutaneous Leishmanaisis Research Center, Mashhad, Iran.

Abstract

Insights

Epstein-Barr virus (EBV) infection is significantly more prevalent in patients with mycosis fungoides (MF), suggesting EBV may play a role in the development of this common skin lymphoma.

Area of Science:

  • Dermatology
  • Oncology
  • Virology

Background:

  • Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma.
  • The etiopathogenesis of MF remains largely unknown, with proposed risk factors including environmental, infectious, and genetic elements.
  • Epstein-Barr virus (EBV), a member of the herpesvirus family, has garnered interest as a potential infectious factor.

Purpose of the Study:

  • To investigate the potential association between Epstein-Barr virus (EBV) infection and the pathogenesis of mycosis fungoides (MF).

Main Methods:

  • A case-control study involving 57 MF patient skin biopsy samples and 57 matched melanocytic nevus control samples.
  • Epstein-Barr virus (EBV) presence was detected using polymerase chain reaction (PCR).
  • Statistical analysis was performed using SPSS version 11.5.

Main Results:

  • EBV was detected in 22 out of 57 MF cases (38.6%) and 4 out of 57 controls (7.0%).
  • A statistically significant higher prevalence of EBV was observed in the MF patient group compared to the control group (P = 0.000).
  • No correlation was found between EBV presence and MF lesion type, patient age, or gender.

Conclusions:

  • The findings suggest that Epstein-Barr virus (EBV) is a potential etiologic agent or promoter in the pathogenesis of mycosis fungoides (MF).
  • Further research is warranted to elucidate the precise role of EBV in MF development.